HCPLive

Rheumatoid Arthritis
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

New Pathway for Reducing the Severity of Rheumatoid Arthritis Symptoms
Researchers have identified a novel chemical compound that can reduce the severity of rheumatoid arthritis symptoms, according to researchers from Montana State University.
Although many patients with arthritis have a difficult time engaging in high-intensity exercises, that may be the very thing they need to reduce their risk for cardiovascular complications associated with the disease.
Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.
Evidence continues to emerge that biologics—in combination with DMARDS—offer a solid line of defense for patients with rheumatoid arthritis at risk of rapid disease progression .
Study results show that mood, whether positive or negative, may impact the discomfort associated with rheumatoid arthritis.
TNF inhibitors can be monitored in rheumatoid arthritis patients using gene expression modules, according to findings published in Arthritis & Rheumatology.
Patients afflicted with moderate-to- severe eczema have been successfully treated with rheumatoid arthritis drug, tofacitinib citrate.

Most Popular

$vacMongoViewPlus$ $vAR$